toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print
  Records Links
Author Agnello, D.; Bigini, P.; Villa, P.; Mennini, T.; Cerami, A.; Brines, M.L.; Ghezzi, P. url  openurl
  Title Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis Type Journal Article
  Year 2002 Publication Brain Research Abbreviated Journal  
  Volume (down) 952 Issue 1 Pages 128-134  
  Keywords Animals; Anti-Inflammatory Agents/*pharmacology; Arthritis, Experimental/drug therapy/immunology; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental/*drug therapy/immunology; Erythropoietin/*pharmacology; Female; Interleukin-6/metabolism; Multiple Sclerosis/drug therapy/immunology; Rats; Rats, Inbred Lew; Research Support, Non-U.S. Gov't; Spinal Cord/immunology/metabolism; Tumor Necrosis Factor-alpha/metabolism  
  Abstract In recent work we reported that systemically administered erythropoietin (EPO) crosses the blood-brain barrier and has protective effects in animal models of cerebral ischemia, brain trauma and in a rat model of experimental autoimmune encephalomyelitis (EAE). Here we characterize the effect of systemic EPO on the inflammatory component of actively induced, acute EAE in Lewis rats. Administration of EPO at doses of 500-5000 U/kg bw i.p., daily from day 3 after immunization with myelin basic protein (MBP), delayed the onset of EAE and decreased its clinical score at peak time (days 12-13). Immunohistochemical analysis of the spinal cord using anti-glial fibrillary acidic protein (GFAP) and anti-CD11b antibodies showed that EPO markedly diminished inflammation and glial activation/proliferation. EAE induced significant levels of TNF and IL-6 in the spinal cord, where IL-6 was maximum at the onset of the disease (day 10) and TNF at its peak (day 12). EPO delayed the increase of TNF levels, without altering their peak levels, and markedly reduced those of IL-6 suggesting that the decreased inflammation and clinical score may be in part upon attenuation of IL-6. On the other hand, EPO was without effect in a model of adjuvant-induced arthritis in Lewis rats, suggesting a specificity towards autoimmune demyelinating diseases. These data suggest that EPO might act as a protective cytokine in inflammatory pathologies of the CNS.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN ISBN Medium  
  Area Expedition Conference  
  Notes 0006-8993 (Print) Journal Article Approved no  
  Call Number refbase @ admin @ Agnello2002 Serial 818  
Permanent link to this record
 

 
Author Jacob, F. openurl 
  Title Complexity and tinkering Type Journal Article
  Year 2001 Publication Ann N Y Acad Sci Abbreviated Journal  
  Volume (down) 929 Issue Pages 71-73  
  Keywords Animals; Consciousness; Evolution, Molecular; Humans; Nerve Tissue Proteins; Neurons  
  Abstract All recent results in the fields of development and evolution point to a role of regulatory circuits as a major cause of evolutionary changes.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number refbase @ user @ Jacob2001 Serial 12119  
Permanent link to this record
 

 
Author Jacob, F. openurl 
  Title Complexity and tinkering Type Journal Article
  Year 2001 Publication Ann N Y Acad Sci Abbreviated Journal  
  Volume (down) 929 Issue Pages 71-73  
  Keywords Animals; Consciousness; Evolution, Molecular; Humans; Nerve Tissue Proteins; Neurons  
  Abstract All recent results in the fields of development and evolution point to a role of regulatory circuits as a major cause of evolutionary changes.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number refbase @ user @ Jacob2001 Serial 12170  
Permanent link to this record
 

 
Author url  openurl
  Title Rheumatic fever and rheumatic heart disease Type Report
  Year 2004 Publication World Health Organization Technical Report Series Abbreviated Journal World Health Organ Tech Rep Ser  
  Volume (down) 923 Issue Pages 1-122, back cover  
  Keywords Adolescent; Adult; Anti-Bacterial Agents/therapeutic use; Child; Child, Preschool; Chronic Disease; Echocardiography, Doppler; Endocarditis/diagnosis/therapy; Heart Valve Diseases/diagnosis/epidemiology/*microbiology/therapy; Humans; *Rheumatic Fever/diagnosis/epidemiology/physiopathology/therapy; Rheumatic Heart Disease/diagnosis/epidemiology/therapy; Streptococcus pyogenes/isolation & purification  
  Abstract Rheumatic heart disease poses a major challenge to public health and is the most prevalent heart disease in children. The major determinants of rheumatic fever and rheumatic heart disease are poverty, malnutrition, overcrowding, poor housing, and a shortage of health-care resources. Although cost-effective strategies for the prevention and control of these diseases are available, they remain underutilized in most developing countries. A World Health Organization Expert Consultation reviewed the current scientific knowledge of rheumatic fever and rheumatic heart disease, as well as medical and public-health practices, and revised the Jones diagnostic criteria for rheumatic fever and rheumatic heart disease. This revision facilitates the diagnosis of: primary episodes of rheumatic fever, recurrent attacks of rheumatic fever in patients with or without rheumatic heart disease, rheumatic chorea, insidious onset rheumatic carditis and chronic rheumatic heart disease. The present report provides practical recommendations for an evidence-based approach to the prevention and management of rheumatic fever and rheumatic heart disease. It also provides practical guidance for implementing cost-effective programmes for controlling these diseases. The report will be of interest to clinicians, policy-makers and public-health professionals.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0512-3054 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:15382606 Approved no  
  Call Number refbase @ user @ Serial 10454  
Permanent link to this record
 

 
Author url  openurl
  Title Rheumatic fever and rheumatic heart disease Type Report
  Year 2004 Publication World Health Organization Technical Report Series Abbreviated Journal World Health Organ Tech Rep Ser  
  Volume (down) 923 Issue Pages 1-122, back cover  
  Keywords Adolescent; Adult; Anti-Bacterial Agents/therapeutic use; Child; Child, Preschool; Chronic Disease; Echocardiography, Doppler; Endocarditis/diagnosis/therapy; Heart Valve Diseases/diagnosis/epidemiology/*microbiology/therapy; Humans; *Rheumatic Fever/diagnosis/epidemiology/physiopathology/therapy; Rheumatic Heart Disease/diagnosis/epidemiology/therapy; Streptococcus pyogenes/isolation & purification  
  Abstract Rheumatic heart disease poses a major challenge to public health and is the most prevalent heart disease in children. The major determinants of rheumatic fever and rheumatic heart disease are poverty, malnutrition, overcrowding, poor housing, and a shortage of health-care resources. Although cost-effective strategies for the prevention and control of these diseases are available, they remain underutilized in most developing countries. A World Health Organization Expert Consultation reviewed the current scientific knowledge of rheumatic fever and rheumatic heart disease, as well as medical and public-health practices, and revised the Jones diagnostic criteria for rheumatic fever and rheumatic heart disease. This revision facilitates the diagnosis of: primary episodes of rheumatic fever, recurrent attacks of rheumatic fever in patients with or without rheumatic heart disease, rheumatic chorea, insidious onset rheumatic carditis and chronic rheumatic heart disease. The present report provides practical recommendations for an evidence-based approach to the prevention and management of rheumatic fever and rheumatic heart disease. It also provides practical guidance for implementing cost-effective programmes for controlling these diseases. The report will be of interest to clinicians, policy-makers and public-health professionals.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0512-3054 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:15382606 Approved no  
  Call Number refbase @ user @ Serial 11128  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: